Literature DB >> 12860373

Low prevalence of smoking in patients with autism spectrum disorders.

Susanne Bejerot1, Lena Nylander.   

Abstract

Psychiatric patients are significantly more often smokers than the general population, the only known exception being obsessive-compulsive disorder (OCD) and catatonic schizophrenia. We have investigated nicotine use in subjects with autism spectrum disorders (ASD). Ninety-five subjects (25 females and 70 males) consecutively diagnosed with any ASD and of normal intelligence were included in the study. Only 12.6% were smokers, compared with 19% in the general population and 47% in a control group of 161 outpatients diagnosed with schizophrenia or a schizophreniform disorder. The results suggest that smoking is rare among subjects with ASD, while the opposite was shown for schizophrenia. If replicated, this finding could suggest biological differences between non-catatonic schizophrenia and ASD, and support the theory of a biological link between ASD and a subtype of OCD, and between ASD and catatonic schizophrenia.

Entities:  

Mesh:

Year:  2003        PMID: 12860373     DOI: 10.1016/s0165-1781(03)00123-9

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  9 in total

1.  Psychiatric comorbidities in autism spectrum disorders: findings from a Danish Historic Birth Cohort.

Authors:  Morsi W Abdallah; Kirstin Greaves-Lord; Jakob Grove; Bent Nørgaard-Pedersen; David M Hougaard; Erik L Mortensen
Journal:  Eur Child Adolesc Psychiatry       Date:  2011-10-05       Impact factor: 4.785

2.  Comorbid psychiatric disorders associated with Asperger syndrome/high-functioning autism: a community- and clinic-based study.

Authors:  Marja-Leena Mattila; Tuula Hurtig; Helena Haapsamo; Katja Jussila; Sanna Kuusikko-Gauffin; Marko Kielinen; Sirkka-Liisa Linna; Hanna Ebeling; Risto Bloigu; Leena Joskitt; David L Pauls; Irma Moilanen
Journal:  J Autism Dev Disord       Date:  2010-09

3.  ADHD symptoms, autistic traits, and substance use and misuse in adult Australian twins.

Authors:  Duneesha De Alwis; Arpana Agrawal; Angela M Reiersen; John N Constantino; Anjali Henders; Nicholas G Martin; Michael T Lynskey
Journal:  J Stud Alcohol Drugs       Date:  2014-03       Impact factor: 2.582

Review 4.  Nicotinic ACh receptors as therapeutic targets in CNS disorders.

Authors:  Kelly T Dineley; Anshul A Pandya; Jerrel L Yakel
Journal:  Trends Pharmacol Sci       Date:  2015-01-29       Impact factor: 14.819

5.  Brief Report: Initial Trial of Alpha7-Nicotinic Receptor Stimulation in Two Adult Patients with Autism Spectrum Disorder.

Authors:  Ann Olincy; Audrey Blakeley-Smith; Lynn Johnson; William R Kem; Robert Freedman
Journal:  J Autism Dev Disord       Date:  2016-12

6.  Health Conditions and Functional Status in Adults with Autism: A Cross-Sectional Evaluation.

Authors:  Robert J Fortuna; Laura Robinson; Tristram H Smith; Jon Meccarello; Beth Bullen; Kathryn Nobis; Philip W Davidson
Journal:  J Gen Intern Med       Date:  2015-09-11       Impact factor: 5.128

7.  A cross-sectional study on oral health and dental care in intellectually able adults with autism spectrum disorder.

Authors:  My Blomqvist; Susanne Bejerot; Göran Dahllöf
Journal:  BMC Oral Health       Date:  2015-07-15       Impact factor: 2.757

8.  Understanding the substance use of autistic adolescents and adults: a mixed-methods approach.

Authors:  Elizabeth Weir; Carrie Allison; Simon Baron-Cohen
Journal:  Lancet Psychiatry       Date:  2021-07-01       Impact factor: 77.056

9.  Long-term effectiveness and safety of varenicline and nicotine replacement therapy in people with neurodevelopmental disorders: A prospective cohort study.

Authors:  Taha Itani; Dheeraj Rai; Tim Jones; Gemma M J Taylor; Kyla H Thomas; Richard M Martin; Marcus R Munafò; Neil M Davies; Amy E Taylor
Journal:  Sci Rep       Date:  2019-12-20       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.